-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Upgrades Merck & Co to Outperform, Raises Price Target to $130

Benzinga·12/18/2025 12:49:17
语音播报
BMO Capital analyst Evan David Seigerman upgrades Merck & Co (NYSE:MRK) from Market Perform to Outperform and raises the price target from $82 to $130.